SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-136048
Filing Date
2023-05-04
Accepted
2023-05-04 16:55:37
Documents
11
Effectiveness Date
2023-05-04

Document Format Files

Seq Description Document Type Size
1 S-3ASR d369975ds3asr.htm S-3ASR 471122
2 EX-1.2 d369975dex12.htm EX-1.2 205419
3 EX-4.4 d369975dex44.htm EX-4.4 301121
4 EX-4.5 d369975dex45.htm EX-4.5 289606
5 EX-5.1 d369975dex51.htm EX-5.1 15022
6 EX-5.2 d369975dex52.htm EX-5.2 8492
7 EX-23.1 d369975dex231.htm EX-23.1 1644
8 EX-FILING FEES d369975dexfilingfees.htm EX-FILING FEES 69494
9 GRAPHIC g369975g0504093823308.jpg GRAPHIC 2747
10 GRAPHIC g369975g24v24.jpg GRAPHIC 76239
11 GRAPHIC g369975g24v26.jpg GRAPHIC 78407
  Complete submission text file 0001193125-23-136048.txt   1580301
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-271650 | Film No.: 23889730
SIC: 2834 Pharmaceutical Preparations